RECRUITING

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

Official Title

EXERT-BCH: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer to Improve Hypertrophy

Quick Facts

Study Start:2024-01-09
Study Completion:2027-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06115486

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years to 89 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast
  2. * Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.
  1. * Any current treatment with cytotoxic chemotherapy for breast cancer
  2. * Inability to safely engage in group sessions of resistance training as deemed by study PI
  3. * Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training

Contacts and Locations

Study Contact

Clinical Trials Contact
CONTACT
4123306151
clinicaltrials@ahn.org

Principal Investigator

Colin Champ, MD, CSCS
PRINCIPAL_INVESTIGATOR
Radiation Oncologist

Study Locations (Sites)

Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
United States

Collaborators and Investigators

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

  • Colin Champ, MD, CSCS, PRINCIPAL_INVESTIGATOR, Radiation Oncologist

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-09
Study Completion Date2027-01

Study Record Updates

Study Start Date2024-01-09
Study Completion Date2027-01

Terms related to this study

Keywords Provided by Researchers

  • Cancer
  • Carcinoma in Situ
  • Hypertrophy
  • Exercise

Additional Relevant MeSH Terms

  • Breast Cancer
  • Breast Carcinoma in Situ
  • Breast Cancer Female